Intended for healthcare professionals


Etoricoxib and diclofenac are associated with similar cardiovascular risks

BMJ 2006; 333 doi: (Published 07 December 2006) Cite this as: BMJ 2006;333:0-i

A momentary lapse of concentration led to a transposition of data when reporting the findings of a recent study in this Short Cuts item by Alison Tonks (BMJ 2006;333:1113, 25 Nov, doi: 10.1136/bmj.333.7578.1113-a). The event rates (of thrombotic cardiovascular events such as heart attack) according to the pooled analysis from three large clinical trials in patients with arthritis should have been given as 1.30 [not 1.24] per 100 patient years for diclofenac and 1.24 [not 1.30] for etoricoxib. The hazard ratio was correct: 0.95 (95% confidence interval 0.81 to 1.11) for etoricoxib v diclofenac, with 0.81 being etoricoxib.

View Abstract